Urine glycosaminoglycan profiles (GAGomes) have high sensitivity for nonmetastatic clear-cell renal cell carcinoma (M0ccRCC) recurrence.

During a live event, Benjamin Garmezy, MD, discussed treatment options in renal cell carcinoma including IO/TKI combinations ...

TFE3 fusion proteins are the oncogenic drivers of translocation renal cell carcinoma but their mechanism of action remains ...

The AUR87A study found that urine collected biomarkers could accurately predict recurrence of kidney cancer in post-surgery ...

Stage 4 non-small cell lung cancer (NSCLC) is the most advanced form of the condition and can be challenging to treat. Treatments include chemotherapy, surgery, immunotherapy, and radiotherapy.

While upper-tract transitional cell carcinoma (TCC) accounts for only 5% of urothelial malignancies, evidence suggests that the frequency of these lesions is increasing Radical nephroureterectomy ...

Source: Getty Images At an early stage, basal cell carcinoma is small and confined, and usually can be cured. When the cancer gets larger and grows deeper in the skin or spreads to other organs ...

Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01) The management of renal cell carcinoma (RCC) has seen significant ...

Subsequently, 250 μL of the cultivated ambience was substituted with a corresponding volume of serum-free cancer stem cell ambience. DMEM/F12, leukemia inhibitory factor (10 ng/mL), basic fibroblast ...

Background: Bone metastasis is a common adverse event in kidney cancer, often resulting ... carcinoma (8120), papillary transitional cell carcinoma (8130), papillary adenocarcinoma (8260), clear-cell ...